IVF Success Rate Rankings in Thailand: Age and Ovarian Reserve Determine Individual True Assessment
AI Summary
AMH 0.6 ng/mL, FSH 14.5 IU/L, bilateral antral follicle count 2–3. These are the test results of a 43-year-old patient in today's clinic. She plans to undergo IVF in Thailand and her first question upon sitting down was: Which hospital has the highest IVF success rate ranking in Thailand?
This question seems straightforward, but answering it requires careful analysis. The success rate is not a fixed number but a probability assessment closely related to multiple variables such as age, ovarian reserve, embryo quality, and laboratory conditions. Directly providing a hospital ranking is neither accurate nor responsible.
Module A: Direct Answer to the QuestionThe True Meaning of IVF Success Rate Rankings in Thailand
Success rate data published by various reproductive centers in Thailand are usually calculated based on specific populations, specific age groups, and specific cycle types. Direct cross-institutional comparisons have limited significance. Success rate rankings are only valuable for reference under the premise of the same age group, similar ovarian reserve, and identical statistical methods. The baseline characteristics of patients vary greatly among different institutions—some centers primarily treat women under 35, while others accept a large number of advanced-age or complex cases. Therefore, the reported crude success rates may differ by 20%–30%, but this does not directly reflect the superiority or inferiority of technical proficiency.
From a clinical perspective, the live birth rate is a more reliable endpoint indicator than the clinical pregnancy rate. The "pregnancy rate" published by some centers includes biochemical pregnancies, which cannot progress to delivery, thus inflating the data without representing the final probability of taking a baby home. When evaluating, it is essential to confirm the statistical measure: whether it is the live birth rate per single frozen embryo transfer or the cumulative live birth rate per oocyte retrieval cycle.
Module C: The Doctor's PerspectiveHow Reproductive Physicians Evaluate Success Rates
In daily outpatient consultations, doctors do not simply answer patients with a single "success rate" number. Instead, they conduct a layered assessment:
- Expected Ovarian Response: Predict the number of eggs obtainable through ovarian stimulation based on AMH, FSH, and antral follicle count.
- Embryo Developmental Potential: Number of eggs retrieved, mature oocyte rate, fertilization rate, and blastocyst formation rate—each step is a critical node affecting the final success rate.
- Cumulative Pregnancy Probability: The pregnancy rate per single transfer vs. the cumulative pregnancy rate after transferring all available embryos from one oocyte retrieval cycle; the latter better reflects the true benefit.
- Patient's Specific Conditions: Presence of adenomyosis, endometrial polyps, chronic endometritis, immune factors, history of previous implantation failure, etc., all modify the estimated success rate.
Therefore, when estimating success rates, experienced reproductive physicians make individualized adjustments based on the above factors, rather than directly citing data from a hospital's official website.
Module D: Differences Across Age Groups + TableDifferences in Success Rates Across Age Groups
Age is the most critical immutable factor affecting IVF success rates. Egg quality declines with age, and the rate of chromosomal aneuploidy increases significantly—a consensus among global reproductive centers. The following data are based on live birth rates (single frozen embryo transfer) published by mainstream reproductive centers in Thailand, incorporating statistical ranges from multiple sources:
| Female Age | Live Birth Rate Reference Range | Notes |
|---|---|---|
| Under 35 | 50% – 60% | Cumulative live birth rate is higher for those with normal ovarian reserve |
| 35 – 37 | 40% – 50% | Egg quality begins to show a declining inflection point |
| 38 – 40 | 25% – 35% | Chromosomal abnormality rate increases significantly |
| 41 – 42 | 15% – 20% | Need to combine with AMH to assess egg retrieval probability |
| 43 – 44 | 5% – 10% | Success rate with own eggs decreases markedly |
| 45 and above | <5% | Most centers recommend evaluating egg donation options |
It is important to note that the above data are based on live birth rates after PGT-A screening of embryos. In cycles without PGT screening, the pregnancy rate may be slightly higher, but the miscarriage rate also increases, and the final live birth rate may not necessarily be higher. Data may vary among different reproductive centers due to differences in laboratory technology and embryo culture systems, but the age gradient trend is consistent.
Furthermore, ovarian reserve function can cause significant differences within the same age group. The number of eggs retrieved and embryos obtained for a 40-year-old woman with AMH 2.0 ng/mL versus AMH 0.4 ng/mL may differ by 3–5 times, directly affecting the cumulative pregnancy rate. Therefore, evaluation should not rely solely on age but must incorporate AMH and antral follicle count.
Module F: Differences Between CentersWhere Do Different Reproductive Centers Differ?
Substantial differences exist among reproductive centers in Thailand in the following aspects, which affect success rates but cannot be simply captured by a "ranking":
- Laboratory Standards: Type of embryo incubator (time-lapse imaging vs. traditional), air quality (HEPA filtration, VOC control), culture media systems, etc., directly impact blastocyst formation rate and embryo quality.
- Embryo Culture Strategy: Some centers primarily transfer day-3 cleavage-stage embryos, while others mainly transfer day-5 blastocysts; the implantation rate for the latter is usually higher.
- Application of PGT Technology: Whether PGT-A is routinely performed, and differences in biopsy techniques and genetic analysis platforms, affect the precision of selecting transferable embryos.
- Patient Selection Criteria: Some centers have lower thresholds for accepting patients of advanced age, with low ovarian reserve, or with repeated failure. The higher the proportion of such patients, the lower the overall success rate data will be.
- Statistical Measures: Some centers publish "clinical pregnancy rate per transfer cycle", while others publish "live birth rate per oocyte retrieval cycle"; the difference between the two can be 10%–20%.
Therefore, when choosing a reproductive center, it is recommended to focus on laboratory quality certifications (e.g., CAP, ISO), embryo culture success indicators (blastocyst formation rate, PGT transferable rate), and data from patient groups similar to your own age and condition.
Module G: Most Easily Overlooked DetailsMost Easily Overlooked Details
1. Differences in Patient Baseline Characteristics
The success rate published by a center is an "average data point," but if you belong to a group such as advanced age, low ovarian reserve, or polycystic ovary syndrome, your actual probability may deviate significantly from the average. Ignoring baseline characteristics and directly comparing rankings is the biggest misconception.
2. Different Statistical Measures
"Clinical pregnancy rate" includes gestational sacs but may not include fetal heartbeat; "ongoing pregnancy rate" usually refers to beyond 12 weeks; "live birth rate" is the ultimate goal. Some centers use "pregnancy rate" instead of "live birth rate" in their publications, and the data gap can exceed 10%.
3. Sample Size
Data from centers with small sample sizes are highly volatile. A center with only a few dozen cycles per year might report a success rate as high as 70%–80%, but the confidence interval is wide and does not represent the true level. It is advisable to refer to data from centers with an annual cycle count of 500 or more.
4. Frozen vs. Fresh Embryo Transfer
Frozen embryo transfer may have a higher implantation rate in some centers, but in fresh transfer cycles, some embryos may not be suitable for freezing. When calculating the cumulative live birth rate, all available embryos must be considered.
Common Pitfalls
- Focusing only on clinical pregnancy rate, ignoring live birth rate: Clinical pregnancy rate includes biochemical pregnancies and early miscarriages and does not represent the final probability of taking a baby home. Request the center to provide live birth rate data and ask for the statistical denominator (per oocyte retrieval cycle or per transfer cycle).
- Being misled by "success stories": Every center has success stories, but individual cases do not represent the overall probability. A 43-year-old succeeding does not mean it is common for 43-year-olds; look at the group data for that age.
- Ignoring cumulative pregnancy rate: A single-transfer success rate of 30% may seem low, but if a cycle yields 3–4 transferable embryos, the cumulative pregnancy rate could reach 60%–70%. Looking only at single-transfer data underestimates the actual benefit.
- Equating "ranking" with "medical quality": A hospital with a high success rate ranking may simply have younger patients or stricter selection criteria, not necessarily better technology. It is essential to assess based on patient group matching.
Interpretation of Key Diagnostic Tests
Before evaluating IVF success rates in Thailand, it is necessary to understand your own baseline indicators. The following three indicators are the core basis for doctors to assess ovarian reserve and formulate stimulation protocols:
AMH (Anti-Müllerian Hormone)
- Normal range: 1.0 – 4.0 ng/mL (varies slightly by age and laboratory)
- AMH < 1.0 ng/mL: Indicates diminished ovarian reserve; number of eggs retrieved may be low, but egg quality is not necessarily poor
- AMH < 0.5 ng/mL: Indicates severely diminished reserve; number of eggs retrieved is usually ≤ 3; need to assess whether attempting a cycle with own eggs is worthwhile
- High AMH (> 4.0 ng/mL): Be alert for polycystic ovary syndrome; caution regarding OHSS risk during stimulation
FSH (Follicle-Stimulating Hormone)
- Baseline value on day 2–3 of menstruation: < 8 IU/L indicates normal ovarian function; 8–12 IU/L is borderline elevated; > 12 IU/L indicates diminished ovarian reserve
- Elevated FSH usually occurs alongside decreased AMH and is a warning sign of poor ovarian response to stimulation
- A single elevated FSH reading cannot be used for diagnosis; it must be interpreted in conjunction with AMH and antral follicle count
Antral Follicle Count (AFC)
- Normal range: Total bilateral antral follicle count ≥ 7 is normal; 5–6 is reduced; ≤ 4 is severely reduced
- AFC directly reflects the number of basal follicles and, together with AMH, predicts the number of eggs retrieved after stimulation
- AFC is influenced by operator experience; it is recommended to have it assessed via ultrasound at an experienced reproductive center
Combining the above three indicators with age can provide a relatively accurate prediction of ovarian response. Thai doctors will choose stimulation protocols (antagonist protocol, PPOS protocol, mild stimulation protocol, etc.) based on these indicators. Different protocols yield different numbers of eggs and embryo quality, indirectly affecting the success rate.
Module R: Observations from PractitionersHaving worked in the field of assisted reproduction for many years, I have observed some recurring phenomena:
- Patients who come for consultation with a "ranking list" often have insufficient knowledge of their own baseline indicators. Many do not know their AMH value or antral follicle count, and some have not even had a semen analysis. It is recommended to complete a comprehensive fertility assessment (female: AMH, FSH, thyroid function, ultrasound; male: semen analysis) before focusing on hospital rankings, to clarify your baseline situation.
- What truly affects the outcome, more often than not, is not "which hospital," but whether the embryo has chromosomal abnormalities. The increase in aneuploidy rates with age is currently irreversible with available technology. PGT-A can help with screening but cannot repair egg quality.
- The technological gap between centers in Thailand is narrowing, but differences in patient management and individualized protocol capabilities still exist. The same stimulation protocol can elicit vastly different responses in different individuals. Experienced doctors adjust medication dynamically based on hormone levels and follicular development, which is far more important than a "fixed ranking."
- Some patients focus excessively on success rate data, neglecting cycle planning and time costs. For advanced-age women with low AMH, waiting for the "best opportunity" or the "highest-ranked hospital" may lead to further decline in ovarian reserve. It is advisable to start the cycle as soon as a decision is made, avoiding unnecessary delays.
Impact of Special Situations on Success Rate
The following conditions can significantly alter the baseline estimate of success rate and should be considered separately during evaluation:
- Previous recurrent implantation failure: Requires investigation of endometrial receptivity, chronic endometritis, immune abnormalities, etc.; success rate may be 10%–20% lower than baseline.
- Male factor: Severe oligoasthenoteratozoospermia or elevated sperm DNA fragmentation index (DFI) can affect fertilization rate and embryo development; assisted methods such as ICSI or TESA may be needed.
- Adenomyosis/fibroids: Abnormal uterine cavity environment can reduce implantation rate; in some cases, surgical pretreatment is required before transfer.
- Abnormal BMI: BMI > 30 or < 18.5 is associated with lower pregnancy rates; it is recommended to adjust to an appropriate range before starting the cycle.
IVF success rate rankings in Thailand should not be the sole basis for choosing a hospital. Any claims of "guaranteed success" or "success rate higher than 80%" should be viewed with caution—the true live birth rate is constrained by age and ovarian reserve, and there is no fixed number applicable to everyone. When obtaining success rate data, request that the hospital provide live birth rate statistics stratified by age and differentiated by transfer cycle type, and focus on cumulative pregnancy rate rather than single-transfer data. For women over 43 or with AMH below 0.5 ng/mL, fully understand the limitations of cycles using own eggs and evaluate alternative options such as egg donation when necessary. All medical decisions should be based on a complete physical examination report and an individualized consultation with a reproductive physician, avoiding decisions made solely based on online rankings.
Time Planning Reminder: For those of advanced age or with low ovarian reserve, it is not advisable to spend too much time on the "choosing a hospital" phase. The rate of AMH decline is faster than most people expect. A complete ovarian stimulation + transfer cycle takes about 2–3 months (including preliminary tests). It is recommended to consult 2–3 centers simultaneously after clarifying your own baseline indicators, compare individualized protocols rather than ranking data, and enter the cycle as soon as possible.
